RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.53%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.32B
AUM Growth
+$1.32B
(+7.1%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
136
New
16
Increased
50
Reduced
27
Closed
17
Top Buys
Top Sells
| 1 |
AbbVie
ABBV
|
$39M |
| 2 |
STJ
St Jude Medical
STJ
|
$33.4M |
| 3 |
TMH
Team Health Holdings Inc
TMH
|
$17M |
| 4 |
ADPT
Adeptus Health Inc.
ADPT
|
$14.4M |
| 5 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$13.5M |
Sector Composition
| 1 | Healthcare | 77.12% |
| 2 | Financials | 3.37% |
| 3 | Industrials | 0.48% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biogen
BIIB
$20.8B
| $15.5M | 1.18% |
50,650
+12,000
| +31% | +$3.68M |
|
27
McKesson
MCK
$85.9B
| $14.3M | 1.08% |
72,500
+2,500
| +4% | +$493K |
|
28
Thermo Fisher Scientific
TMO
$183B
| $14.2M | 1.07% |
100,000
| – | – |
|
29
Pediatrix Medical
MD
$1.45B
| $13.8M | 1.05% |
193,000
+68,000
| +54% | +$4.87M |
|
30
Incyte
INCY
$17B
| $13.8M | 1.04% |
127,000
+14,000
| +12% | +$1.52M |
|
31
Galapagos
GLPG
$2.06B
| $13.2M | 1% |
210,000
| – | – |
|
32
Amgen
AMGN
$153B
| $13.1M | 1% |
80,900
-2,350
| -3% | -$381K |
|
33
Travere Therapeutics
TVTX
$1.75B
| $13M | 0.99% |
675,000
-8,900
| -1% | -$172K |
|
34
Ardelyx
ARDX
$1.57B
| $12.4M | 0.94% |
682,500
+1,000
| +0.1% | +$18.1K |
|
35
TherapeuticsMD
TXMD
$12.7M
| $12.3M | 0.93% |
1,185,000
+410,000
| +53% | +$4.25M |
|
|
ACHN
36
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $11.9M | 0.9% |
1,105,000
-20,000
| -2% | -$216K |
|
37
Ultragenyx Pharmaceutical
RARE
$3.04B
| $11.8M | 0.9% |
105,500
-1,500
| -1% | -$168K |
|
|
KDNY
38
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.7M | 0.88% |
415,000
| – | – |
|
|
PRAH
39
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.5M | 0.87% |
253,000
| – | – |
|
40
Jazz Pharmaceuticals
JAZZ
$7.99B
| $11.3M | 0.86% |
80,300
+28,800
| +56% | +$4.05M |
|
41
Penumbra
PEN
$10.5B
| $11M | 0.84% |
205,000
+10,000
| +5% | +$538K |
|
|
WMGI
42
DELISTED
Wright Medical Group Inc
WMGI
| $11M | 0.84% |
+456,000
| New | +$11M |
|
43
Theravance Biopharma
TBPH
$691M
| $10.6M | 0.8% |
645,000
+42,500
| +7% | +$697K |
|
|
DERM
44
DELISTED
Dermira, Inc.
DERM
| $10M | 0.76% |
290,000
-10,001
| -3% | -$346K |
|
|
INSY
45
DELISTED
Insys Therapeutics, Inc.
INSY
| $9.69M | 0.73% |
338,500
+30,500
| +10% | +$873K |
|
|
ITCI
46
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.68M | 0.73% |
180,000
| – | – |
|
|
CORV
47
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $9.65M | 0.73% |
1,190,000
| – | – |
|
|
CHMA
48
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $9.54M | 0.72% |
487,500
-35,000
| -7% | -$685K |
|
49
Idexx Laboratories
IDXX
$50.7B
| $9.3M | 0.7% |
127,500
+15,000
| +13% | +$1.09M |
|
|
ADAP
50
Adaptimmune Therapeutics
ADAP
$13.9M
| $9.23M | 0.7% |
765,001
+8,901
| +1% | +$107K |
|